With 1 ETF traded in the U.S. markets, Dynamic Pharmaceutical Intellidex Index ETF gathers total assets under management of $302.91M. The average expense ratio is 0.58%. Dynamic Pharmaceutical Intellidex Index ETF can be found in the following asset class:
See details on the top-performing pharma ETFs and the benefits and risks of investing.
The debut highlights the lack of funds focused on the area.
New 3X fund offers leveraged smart-beta exposure to the pharma space.
After a slow start to the year for closures, it looks like March will at least match its level of fund shutdowns from the prior year.
Since the U.S. stock market bottomed seven years ago, these equity ETFs have risen sharply.
Some popular smart-beta funds managed to outperform their plain-vanilla counterparts.
A look at which ‘smart beta’ funds are top and bottom performers so far this year.
A look at which ‘smart beta’ funds are top and bottom performers so far this year.
These funds showed the best returns during this six-year bull run.